Evaluation of tadalafil for the treatment of erectile dysfunction.
- Author:
Zhi-Yong LIU
1
;
Ying-Hao SUN
Author Information
1. Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
- Publication Type:Journal Article
- MeSH:
Carbolines;
therapeutic use;
Diabetes Mellitus;
drug therapy;
physiopathology;
Erectile Dysfunction;
drug therapy;
physiopathology;
Humans;
Hypertension;
drug therapy;
physiopathology;
Male;
Phosphodiesterase Inhibitors;
therapeutic use;
Tadalafil;
Treatment Outcome
- From:
National Journal of Andrology
2008;14(4):377-380
- CountryChina
- Language:Chinese
-
Abstract:
Tadalafil is an oral phosphodiesterase type-5 inhibitor for male erectile dysfunction (ED). It has been proved to improve erectile function, with safety and effectiveness lasting up to 36 h, allowing patients to choose when to have sexual activities. Tadalafil is also efficacious in the treatment of ED associated with such diseases as hypertension, diabetes mellitus, etc. This article reviews the available evidence for the efficacy of tadalafil on ED and related diseases.
